Long noncoding RNA expressing genomic elements that control antibody diversification and chromosomal integrity in B cells

表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA

基本信息

  • 批准号:
    10531294
  • 负责人:
  • 金额:
    $ 58.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-07 至 2027-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Background. It is now evident that the majority of the mammalian genome has the potential to express non- coding RNAs (ncRNAs). However, the functionality and mechanism(s) of regulation of these ncRNAs are just beginning to be explored. One challenge that biologists encounter is the detection of these ncRNAs, which often tend to be transcriptionally tightly controlled and rapidly degraded. Using mouse models that allow easy detection of lncRNA, we have recently identified a set of long noncoding RNAs (lncRNA) that are expressed surrounding the immunoglobulin loci genes. These lncRNAs are placed inside topologically associating domains (TADs) that are formed during B cell development. Experiments using mouse models that lack these lncRNAs (published and preliminary data) demonstrate roles in class switch recombination and somatic hypermutation mechanisms. Objectives/Hypothesis. Here we investigate the direct role of lncRNAs in regulating genome local architecture and DNA topology via cis and trans mechanisms. In aim 1: we evaluate the physiological role of lncRNA-expressing loci in regulating IgH recombination via organizing TADIgH; in aim 2, we understand the molecular mechanisms through which lncRNAs are used to control genome architecture; and in aim 3, we focus on understanding the function of lncRNA SµGLT in control of CSR. Study Design: Using mouse models and cell lines that are deficient in specific lncRNAs we aim to investigate their immunologically relevant functions. For evaluating the molecular mechanism of action of the lncRNAs we use biochemical assays to purify lncRNA interacting proteins and perform chromosomal architecture assays such as HiC and 4C-seq. Finally, we perform high-throughput sequencing experiments to evaluate the lncRNA's effect(s) on SHM in the Ig loci genes and elsewhere. Disease Relevance: The proposed studies will lead to a better understanding of the mechanisms in B cell development and function. The lncRNAs being investigated in this application carry polymorphisms in patients with IgA deficiency syndrome and thus our study is relevant for human physiology. Finally, antibody diversification mechanisms are essential for immune system homeostasis but when these mechanisms fail there are increased genomic alterations that are associated with lymphomas. Thus, this study is related with both immunity and lymphomagenesis.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Uttiya Basu其他文献

Uttiya Basu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Uttiya Basu', 18)}}的其他基金

FASEB's "The RNA Associated Mechanisms Conference: In Immunity and Disease"
FASEB 的“RNA 相关机制会议:免疫与疾病”
  • 批准号:
    9993686
  • 财政年份:
    2021
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10461710
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    9897023
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10721410
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10259665
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10598241
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10682918
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10683111
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10303057
  • 财政年份:
    2017
  • 资助金额:
    $ 58.96万
  • 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10065485
  • 财政年份:
    2017
  • 资助金额:
    $ 58.96万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了